CN102512474B - Ointment for treating nasal polyp - Google Patents

Ointment for treating nasal polyp Download PDF

Info

Publication number
CN102512474B
CN102512474B CN2011104365167A CN201110436516A CN102512474B CN 102512474 B CN102512474 B CN 102512474B CN 2011104365167 A CN2011104365167 A CN 2011104365167A CN 201110436516 A CN201110436516 A CN 201110436516A CN 102512474 B CN102512474 B CN 102512474B
Authority
CN
China
Prior art keywords
artificial
ointment
vaseline
scorpio
herba centipedae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2011104365167A
Other languages
Chinese (zh)
Other versions
CN102512474A (en
Inventor
张敬珍
Original Assignee
张敬珍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 张敬珍 filed Critical 张敬珍
Priority to CN2011104365167A priority Critical patent/CN102512474B/en
Publication of CN102512474A publication Critical patent/CN102512474A/en
Application granted granted Critical
Publication of CN102512474B publication Critical patent/CN102512474B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention discloses an ointment for treating nasal polyp. The ointment comprises the following components: 0.05-0.15g artificial bezoar, 0.05-0.15g artificial musk, 0.1-0.5g scorpion, 0.25-0.75g Herba Centipedae, 0.1-0.5g dry dandelion, 0.2g cooling oil and 0.5g vaseline. a production process comprises the following steps: crushing artificial bezoar, artificial musk, scorpion, Herba Centipedae and dry dandelion into fine powder capable of passing through a sieve with 270 meshes, then taking artificial bezoar, artificial musk, scorpion, Herba Centipedae and dry dandelion with the above ratio, and finally adding cooling oil and vaseline with the proportion, uniformly mixing and packaging. The ointment for treating nasal polyp has the advantages of easy usage, and no toxic and side effect, and the clinical tests of 500 patients show that the cure rate is 100%.

Description

A kind ofly treat polypous ointment
Technical field
The present invention relates to a kind of ointment, especially a kind of polypous ointment.
Background technology
Nasal polyp is the smooth surface in the nose key, translucent, softness touched and bitterly vegetation not, and this vegetation is hindered breath, shows as persistence and has a stuffy nose.The nasal obstruction reason is because nasal cavity blood capillary circulation is not smooth, causes capillary dilation and causes, uses the vasoconstrictor collunarium without obvious curative effects, the patient also can cause hyposmia because of nasal obstruction, closed rhinolalia, sleep snoring and mouth breathing, but secondary chronic pharyngitis of a specified duration.Nasal polyp is early stage, and patient's intranasal seemingly has the nasal mucus of can not blowing, and mostly is serosity, if accompanying infection can have purulent secretion.The patient is sneeze seldom, if but nasal mucosa has allergic inflammation, and also can sneeze.If in time do not find the state of an illness, nasal polyp can continue to increase, and nasal obstruction is obviously increased the weight of, and can cause headache or dizzy, hyposmia so that disappearance.If polyp blocks choana, even charge into nasopharynx part, can cause auditory dysesthesia, also can cause bridge of the nose broadening, form in " frog nose ".
At present, treating polypous main method is operative treatment, utilizes operative treatment to have certain risk.Therefore, the polypous ointment for the treatment of of a kind of external of research is the present technical issues that need to address.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of polypous ointment for the treatment of.
The technical scheme that the present invention solves its technical problem is:
a kind ofly treat polypous ointment, its constituent is: artificial Calculus Bovis 0.05~0.15g, artificial Moschus 0.05~0.15g, Scorpio 0.1~0.5g, Herba Centipedae 0.25~0.75g, dried Herba Taraxaci 0.1~0.5g, menthocamphorate 0.2g, vaseline 0.5g, its processing technology is: at first with the artificial Calculus Bovis, the artificial Moschus, Scorpio, Herba Centipedae, dried Herba Taraxaci pulverizes into and can pass through 270 eye mesh screen fine powders, then measure according to the above ratio the artificial Calculus Bovis, the artificial Moschus, Scorpio, Herba Centipedae, dried Herba Taraxaci powder, add in proportion at last menthocamphorate and vaseline, mixing well pack gets final product.
The optimal technical scheme that the present invention solves its technical problem is:
Its constituent is: artificial Calculus Bovis 0.1g, artificial Moschus 0.1g, Scorpio 0.3g, Herba Centipedae 0.5g, dried Herba Taraxaci 0.3g, menthocamphorate 0.2g, vaseline 0.5g.
Therapeutic Method:
With ointment obliterating of the present invention affected part, every day, each once, can fully recover in 30~35 days sooner or later.
Compared with prior art, the present invention is easy to use, has no side effect, through 500 routine patient clinicals, cure rate 100%.
Illustrate therapeutic effect of the present invention below by several model cases:
Case one, the field so-and-so, the man, 23 years old, area just outside a city gate town, Quzhou County, Hebei people from North Street suffered from nasal polyp.Adopt medicinal ointment therapy of the present invention, recovery from illness on the 3rd was not recurred after recovery from illness.
Case two, Zhao so-and-so, the female, 33 years old, western fort people opened in Yongnian County, Hebei, suffered from nasal polyp, adopted medicinal ointment therapy of the present invention, fully recovered in 3rd.
Case three, Lee so-and-so, the man, 24 years old, beam tube people from town, Daming County, Hebei suffered from nasal polyp, adopts medicinal ointment therapy of the present invention, recovery from illness on the 3rd is recurred for many years.
Case four, military so-and-so, the female, 17 years old, Handan City's Congtai District was suffered from nasal polyp, adopts medicinal ointment therapy of the present invention, fully recovered in 3rd.
Case five, Hao so-and-so, the female, 20 years old, the Hanshan District people of Handan City suffered from nasal polyp, adopts medicinal ointment therapy of the present invention, fully recovered in 3rd.
The specific embodiment
Enumerate 10 specific embodiments of the present invention below by the mode of list; whole compositions are market and directly buy; its processing technology is: at first artificial Calculus Bovis, artificial Moschus, Scorpio, Herba Centipedae, dried Herba Taraxaci are pulverized into and can pass through 270 eye mesh screen fine powders; then measure according to the above ratio artificial Calculus Bovis, artificial Moschus, Scorpio, Herba Centipedae, dried Herba Taraxaci powder; add in proportion at last menthocamphorate and vaseline, mix well pack and get final product.
Unit: g

Claims (2)

1. treat polypous ointment for one kind, it is characterized in that: its constituent is: artificial Calculus Bovis 0.05~0.15g, artificial Moschus 0.05~0.15g, Scorpio 0.1~0.5g, Herba Centipedae 0.25~0.75g, dried Herba Taraxaci 0.1~0.5g, menthocamphorate 0.2g, vaseline 0.5g, its processing technology is: at first with the artificial Calculus Bovis, the artificial Moschus, Scorpio, Herba Centipedae, dried Herba Taraxaci pulverizes into and can pass through 270 eye mesh screen fine powders, then measure according to the above ratio the artificial Calculus Bovis, the artificial Moschus, Scorpio, Herba Centipedae, dried Herba Taraxaci powder, add in proportion at last menthocamphorate and vaseline, mixing well pack gets final product.
2. a kind of polypous ointment for the treatment of according to claim 1, it is characterized in that: its constituent is: artificial Calculus Bovis 0.1g, artificial Moschus 0.1g, Scorpio 0.3g, Herba Centipedae 0.5g, dried Herba Taraxaci 0.3g, menthocamphorate 0.2g, vaseline 0.5g.
CN2011104365167A 2011-12-23 2011-12-23 Ointment for treating nasal polyp Expired - Fee Related CN102512474B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011104365167A CN102512474B (en) 2011-12-23 2011-12-23 Ointment for treating nasal polyp

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011104365167A CN102512474B (en) 2011-12-23 2011-12-23 Ointment for treating nasal polyp

Publications (2)

Publication Number Publication Date
CN102512474A CN102512474A (en) 2012-06-27
CN102512474B true CN102512474B (en) 2013-06-26

Family

ID=46283727

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011104365167A Expired - Fee Related CN102512474B (en) 2011-12-23 2011-12-23 Ointment for treating nasal polyp

Country Status (1)

Country Link
CN (1) CN102512474B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102772539B (en) * 2012-07-31 2016-02-17 富阳原野生物科技有限公司 A kind of tincture dose medicament for the treatment of asthenic cold type nasal polyp

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1295850A (en) * 1999-11-15 2001-05-23 许其宽 Bitongling mixture injection for curing nasal obstruction
CN102247438A (en) * 2010-05-18 2011-11-23 马赛香 Medicine for dredging nasal orifice through application method of sniffing

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1295850A (en) * 1999-11-15 2001-05-23 许其宽 Bitongling mixture injection for curing nasal obstruction
CN102247438A (en) * 2010-05-18 2011-11-23 马赛香 Medicine for dredging nasal orifice through application method of sniffing

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
中西医结合治疗慢性鼻窦炎鼻息肉;陈国春;《福建中医学院学报》;20050810;第15卷(第04期);全文 *
中西医结合治疗慢性鼻窦炎鼻息肉;陈萍等;《上海中医药杂志》;20060415;第40卷(第04期);全文 *
中西医结合治疗慢性鼻窦炎鼻息肉54例;周文茹等;《江苏中医药》;20040110;第24卷(第12期);全文 *
周文茹等.中西医结合治疗慢性鼻窦炎鼻息肉54例.《江苏中医药》.2004,第24卷(第12期),全文.
慢性上颌窦炎的临床研究近况;肖辉良;《江西中医药》;19960421;第27卷(第02期);全文 *
李文波等.治鼻息肉方.《中国民间疗法》.2003,第11卷(第06期),全文.
治鼻息肉方;李文波等;《中国民间疗法》;20030628;第11卷(第06期);全文 *
肖辉良.慢性上颌窦炎的临床研究近况.《江西中医药》.1996,第27卷(第02期),全文.
陈国春.中西医结合治疗慢性鼻窦炎鼻息肉.《福建中医学院学报》.2005,第15卷(第04期),全文.
陈萍等.中西医结合治疗慢性鼻窦炎鼻息肉.《上海中医药杂志》.2006,第40卷(第04期),全文.

Also Published As

Publication number Publication date
CN102512474A (en) 2012-06-27

Similar Documents

Publication Publication Date Title
CN103142785B (en) Rhinitis treatment medicine
CN103623267B (en) Medication for treating allergic rhinitis
CN103566344B (en) Blood-invigorating and muscles and joints-relaxing paste
CN1294930C (en) Medication for treating cough caused by inflammation of upper respiratory tract
CN102512474B (en) Ointment for treating nasal polyp
CN103316086B (en) Tibetan medicine for treating influenza and preparation method thereof
CN101019906A (en) Chinese medicine for relieving cough, eliminating phlegm and relieving asthma
CN103142857B (en) Chinese medicinal granules for treating bronchitis combined emphysema and preparation method thereof
CN103356988B (en) Traditional Chinese medicine preparation for treating bronchus asthma of children
CN104940288A (en) Medicine for treating common-cold fever and headache
CN102512462A (en) Ointment for treating rhinitis
CN107929366A (en) A kind of Chinese medicine composition for treating allergic rhinitis
CN103638189B (en) The Chinese medicine preparation for the treatment of acute pharyngitis
CN102151224B (en) Infantile cerebral palsy acupuncture point heat treatment plaster
CN102940873B (en) Externally used medicine composition for treating sprains and preparation method thereof
CN105582376A (en) Externally-used traditional Chinese medicine for treating rubella
CN102755607B (en) Medicine for treating bronchitis and asthma and preparation method thereof
CN105125880A (en) Traditional Chinese medicine for treating chronic tonsillitis
CN105169009A (en) Application of traditional Chinese medicine composition in preparation of medicine for treating viral influenza
CN105213615A (en) Compound Solanum Nigrum Pianomide
WO2016078152A1 (en) Chill-dispelling traditional chinese medicine
CN104042905A (en) Traditional Chinese medicine for treating nasosinusitis
CN102512478B (en) Chronic pharyngitis oral liquid
CN107496740A (en) A kind of pill medicine for treating children's abundant expectoration cough and asthma and preparation method thereof
CN104940336A (en) Medicine for treating cough due to pathogenic wind-cold

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130626

Termination date: 20131223